Patricia A Missall

Patricia A Missall, MD, PhD, FAAD

Program Director & Clinical Associate Professor

Department: MD-DERMATOLOGY
Business Phone: (352) 594-1500

About Patricia A Missall

Dr. Missall is a great addition to the department bringing her expertise in both general dermatology and dermatopathology with board certifications in both specialties. Dr. Missall’s practice focuses primarliy on skin cancer and pigmented lesions. She is an associate professor and practices at the Springhill clinic.

Accomplishments

Academic Dermatology Leadership Program
2018 · AAD
Jesuit Honor Society
2003 · Alpha Sigma Nu
The Scientific Research Society
2002 · Sigma Xi
National Mathematics Honor Society
2000 · Pi Mu Epsilon
National Physics Honor Society
2000 · Sigma Pi Sigma
National Honor Society
1996 · Phi Beta Kappa

Board Certifications

  • Dermatology
    American Board of Dermatology
  • Dermatopathology
    American Boards of Dermatology and Pathology

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0001-9062-0606

Publications

2021
scRNA-Seq Reveals New Enteric Nervous System Roles for GDNF, NRTN, and TBX3.
Cellular and molecular gastroenterology and hepatology. 11(5):1548-1592.e1 [DOI] 10.1016/j.jcmgh.2020.12.014. [PMID] 33444816.
2020
Cutaneous intestinal metaplasia: An unusual cause of peristomal complication with malignant potential
Journal of Cutaneous Pathology. 47(5):479-480 [DOI] 10.1111/cup.13631.
2020
TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosis
Journal of Cutaneous Pathology. 47(8):710-719 [DOI] 10.1111/cup.13691.
2019
Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.
Journal of the American Academy of Dermatology. 80(1):189-207.e11 [DOI] 10.1016/j.jaad.2018.04.033. [PMID] 29689323.
2018
Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology
Journal of Cutaneous Pathology. 45(8):563-580 [DOI] 10.1111/cup.13142.
2018
Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists
Journal of Cutaneous Pathology. 45(11):839-846 [DOI] 10.1111/cup.13327.
2018
Granuloma Annulare in the Setting of Secukinumab.
Case reports in dermatological medicine. 2018 [DOI] 10.1155/2018/5175319. [PMID] 29805815.
2018
The Monothiol Glutaredoxin Grx4 Regulates Iron Homeostasis and Virulence in Cryptococcus neoformans.
mBio. 9(6) [DOI] 10.1128/mBio.02377-18. [PMID] 30514787.
2017
Ulcerative necrobiosis lipoidica in the setting of anti-tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis.
JAAD case reports. 3(2):127-130 [DOI] 10.1016/j.jdcr.2017.01.006. [PMID] 28331899.
2015
Clinicopathologic evaluation of cardiofaciocutaneous syndrome: overcoming the challenges of diagnosing a rare genodermatosis.
Pediatric dermatology. 32(1):e23-8 [DOI] 10.1111/pde.12494. [PMID] 25514835.
2014
Granulomatous mycosis fungoides with clinical features of granulomatous slack skin.
Cutis. 93(3):E4-5 [PMID] 24738107.
View on: PubMed
2013
Prominent follicular mucinosis with diffuse scalp alopecia resembling alopecia areata.
Journal of cutaneous pathology. 40(10):887-90 [DOI] 10.1111/cup.12201. [PMID] 23962142.
2012
Identification of Helicobacter pylori in skin biopsy of prurigo pigmentosa.
The American Journal of dermatopathology. 34(4):446-8 [DOI] 10.1097/DAD.0b013e318231ae4a. [PMID] 22197863.
2010
Lentiginous melanoma in situ treatment with topical imiquimod: need for individualized regimens.
Archives of dermatology. 146(11):1309-10 [DOI] 10.1001/archdermatol.2010.338. [PMID] 21079078.
2009
Immunohistochemical differentiation of four benign eccrine tumors.
Journal of cutaneous pathology. 36(2):190-6 [DOI] 10.1111/j.1600-0560.2008.00991.x. [PMID] 18564284.
2009
The use of imiquimod to minimize the surgical defect when excising invasive malignant melanoma surrounded by extensive melanoma in situ, lentiginous type.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 35(5):868-74 [DOI] 10.1111/j.1524-4725.2009.01146.x. [PMID] 19389091.
2006
Posttranslational, translational, and transcriptional responses to nitric oxide stress in Cryptococcus neoformans: implications for virulence.
Eukaryotic cell. 5(3):518-29 [PMID] 16524907.
View on: PubMed
2005
Distinct stress responses of two functional laccases in Cryptococcus neoformans are revealed in the absence of the thiol-specific antioxidant Tsa1.
Eukaryotic cell. 4(1):202-8 [PMID] 15643075.
View on: PubMed
2005
Function of the thioredoxin proteins in Cryptococcus neoformans during stress or virulence and regulation by putative transcriptional modulators.
Molecular microbiology. 57(3):847-58 [PMID] 16045626.
View on: PubMed
2005
Thioredoxin reductase is essential for viability in the fungal pathogen Cryptococcus neoformans.
Eukaryotic cell. 4(2):487-9 [PMID] 15701811.
View on: PubMed
2005
Two glutathione peroxidases in the fungal pathogen Cryptococcus neoformans are expressed in the presence of specific substrates.
Microbiology (Reading, England). 151(Pt 8):2573-2581 [DOI] 10.1099/mic.0.28132-0. [PMID] 16079336.
2004
Mechanisms of resistance to oxidative and nitrosative stress: implications for fungal survival in mammalian hosts.
Eukaryotic cell. 3(4):835-46 [PMID] 15302816.
View on: PubMed
2004
Thiol peroxidase is critical for virulence and resistance to nitric oxide and peroxide in the fungal pathogen, Cryptococcus neoformans.
Molecular microbiology. 51(5):1447-58 [PMID] 14982637.
View on: PubMed

Education

Dermatopathology Fellowship
2012-2013 · Saint Louis University
Dermatology Residency
2009-2012 · Saint Louis University
Internal Medicine Internship
2008-2009 · Saint Louis University
M.D., Ph.D.
2001-2008 · Saint Louis University, School of Medicine
B.A.
1997-2001 · Drew University

Contact Details

Phones:
Business:
(352) 594-1500